A new study revealed divergent policies on artificial intelligence (AI) use in peer review among leading medical journals, ...

Women who had children had a higher risk of reaching a visual acuity below 6/24 compared with those who did not have children ...

Recent insights shed light onto the most effective diagnostic tools for laryngeal myasthenia gravis (MG), a poorly understood ...

With new CDC data expressing optimism about the epidemic of sexually transmitted infections (STIs), take a look at the ...

Gene therapies can be life-changing for people, but the high cost plus the burden of treatment remain barriers to access and ...

Presentations at the 2024 Asembia Specialty Pharmacy Summit focused on reshaping specialty pharmacy while keeping patients ...

Experts are now urging the inclusion of sickle cell disease in the global health agenda to address disparities in treatment access. From 2000 to 2021, global births of babies with SCD rose by 13.7%, ...

The median launch prices in the US increased from $29,630 (IQR, $1322-$49,691) for drugs approved in 201 to $84,240 (IQR, ...